illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10
K151046 is the FDA 510(k) clearance record for illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10, a class II device, cleared for Meridian Bioscience, Inc. on under FDA product code PGI (Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples). FDA's definition for product code PGI reads: "For the qualitative detection and differentiation of VZV, HSV1, HSV2- DNA in cutaneous and mucocutaneous lesion samples from symptomatic patients. The assay is not intended for use with cerebral spinal fluid". FDA records list 38 510(k) clearances for Meridian Bioscience, Inc., from to . As of , FDA records show no recalls naming K151046.
Clearance record
- Decision date
- Received
- (88 days to decision)
- Product code
- PGI Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples
- Regulation
- 21 CFR 866.3309
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Meridian Bioscience, Inc. 3471 River Hills Dr., Cincinnati OH
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code PGI
Trailing 12 monthsFDA records hold no clearances under product code PGI in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
